Olokizumab Biosimilar – Anti-IL6 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system |
Description of Olokizumab Biosimilar - Anti-IL6 mAb - Research Grade
Description of Olokizumab Biosimilar - Anti-IL6 mAb - Research Grade
General information on Anti-IL6[Homo sapiens] (Olokizumab) Monoclonal Antibody
Olokizumab has been investigated for the treatment of Crohn’s Disease.
Product name | Olokizumab Biosimilar - Anti-IL6 mAb - Research Grade |
---|---|
Source | CAS 1007223-17-7 |
Species | Humanized |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | CDP 6038 |
Reference | PX-TA1247 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4-kappa |
Clonality | Monoclonal Antibody |
Source | CAS 1007223-17-7 |
Product name | Olokizumab Biosimilar - Anti-IL6 mAb - Research Grade |
---|---|
Source | CAS 1007223-17-7 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | CDP 6038 |
Reference | PX-TA1247 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4-kappa |
Clonality | Monoclonal Antibody |
Source | CAS 1007223-17-7 |
Reviews
There are no reviews yet.